The exercise status for Series 8 to Series 10 stock acquisition rights for October 2026 is disclosed. The total number of issued shares is 10,923,800 shares and paid-in capital increased to 2,604 million yen. In October, actual exercises occurred only for Series 8: a total of 2,500 warrants were exercised (resulting in 2,500 new shares issued). The number of shares to be delivered was 250,000 shares (Series 8) and 0 shares (Series 9\u201310). Unexercised rights remain unchanged at a total of 18,400 warrants (1,840,000 shares) and 20,000 warrants (2,000,000 shares), and 58,673 warrants (5,867,300 shares).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3083","jir_company_name":"Star seeds Co.,Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/3083-20261102-01.pdf","jir_short_summary":"The exercise status for Series 8 to Series 10 stock acquisition rights for October 2026 is disclosed. The total number of issued shares is 10,923,800 shares and paid-in capital increased to 2,604 million yen. In October, actual exercises occurred only for Series 8: a total of 2,500 warrants were exercised (resulting in 2,500 new shares issued). The number of shares to be delivered was 250,000 shares (Series 8) and 0 shares (Series 9\u201310). Unexercised rights remain unchanged at a total of 18,400 warrants (1,840,000 shares) and 20,000 warrants (2,000,000 shares), and 58,673 warrants (5,867,300 shares).","jir_summary":"### Overview of Monthly Exercise Status of Stock Acquisition Rights\nStar seeds Co.,Ltd. disclosed the exercise status of Series 8 to Series 10 stock acquisition rights for October 2026. The total number of issued shares for the month was 10,923,800 shares and paid-in capital was 2,604 million yen, reflecting an increase in total shares compared with the end of the previous month. For Series 8, a total of 30,000 shares were to be delivered, of which 2,500 warrants were exercised and transferred as new shares. The monthly exercise ratio was 8.3%. There were zero exercises for Series 9 and Series 10. Unexercised rights remained constant for each series; unexercised shares range between 1,840,000 shares and 2,000,000 shares in total, and relative to 5,867,300 shares the figure is 58,673 warrants.\n\n### Impact on Shareholders and Outlook\nThis disclosure is a voluntary communication to investors regarding the exercise status of the company's stock acquisition rights and does not indicate implementation of any specific capital policy. However, tracking increases in the total number of issued shares and the status of unexercised rights provides information for assessing potential dilution. While a certain number of Series 8 warrants were actually exercised, Series 9 and Series 10 saw no exercises; future exercise activity could change the extent of dilution depending on developments.","jir_financial_highlights":"Total number of issued shares: 10,923,800 shares (Month-end vs prior month +2,292,700 shares (increase in total issued shares))\nPaid-in capital: 2,604 million yen (Increased by 1,117 million yen as of the end of the same month)\nSeries 8 Stock Acquisition Rights Exercise Status: Number of shares to be delivered 30,000 shares; number of exercised warrants 2,500 warrants (Monthly exercise ratio 8.3% (against total issued 30,000 warrants))","jir_category":"","jir_hashtags":"#StarSeedsCoLtd, #StockAcquisitionRights, #StockOptions","jir_key_figures":"Total number of issued shares: 10,923,800 shares\nPaid-in capital: 2,604 million yen\nSeries 8 Stock Acquisition Rights Exercise Status: 2,500 warrants \/ total issued 30,000 warrants (8.3%)","jir_meta_title":"Star seeds Co.,Ltd. \u2014 Monthly Exercise Status of Stock Acquisition Rights | October 2026","jir_meta_description":"Star seeds Co.,Ltd. discloses the exercise status of Series 8 to Series 10 stock acquisition rights for October 2026, detailing the increase in total issued shares, Series 8 exercise results, and the status of unexercised rights.","jir_og_title":"Star seeds Co.,Ltd. \u2014 Monthly Exercise Status of Stock Acquisition Rights | October 2026","jir_og_description":"Star seeds Co.,Ltd. announces the exercise status of stock acquisition rights for October 2026, explaining the increase in total issued shares and summarized exercise results.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59651,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-139514","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n